Somatic TP53 mutations occur in almost every type of cancer at rates from 38% to 50% in ovarian, esophageal, colorectal, head and neck, larynx, and lung cancers to about 5% in primary leukemia sarcoma, testicular cancer, malignant melanoma, and cervical cancer [18]. Here, TP53 is linked to lung carcinoma.